Lite Strategy, Inc. Weighted Average Number of Shares Outstanding, Basic and Diluted
Lite Strategy, Inc. (LITS) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 73.63 million shares for the 3-month period ending 2019-09-30, per its 10-Q filed 2019-11-07.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2019-11-07
- Lite Strategy, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2019-09-30 was 73.63M shares, a 3.87% increase year-over-year.
- Lite Strategy, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2018-09-30 was 70.89M shares.
- Lite Strategy, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2016-09-30 was 35.75M shares, a 4.12% increase year-over-year.
- Lite Strategy, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2016-06-30 was 34.42M shares, a 0.45% increase year-over-year.
- Lite Strategy, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2016 was 34.40M shares, a 21.97% increase from fiscal 2015.
- Lite Strategy, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2015 was 28.20M shares, a 40.59% increase from fiscal 2014.
- Lite Strategy, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2014 was 20.06M shares, a 97.44% increase from fiscal 2013.
- Lite Strategy, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2013 was 10.16M shares, a 352.05% increase from fiscal 2012.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|
| 2019-09-30 | 73.63M shares 10-Q · filed 2019-11-07 | |||||
| 2018-09-30 | 70.89M shares 10-Q · filed 2019-11-07 | |||||
| 2016-09-30 | 35.75M shares 10-Q · filed 2016-11-09 | 35.08M shares derived: average of 2 quarters · filed 2016-11-09 | 34.86M shares derived: average of 3 quarters · filed 2016-11-09 | 34.75M shares derived: average of 4 quarters · filed 2016-11-09 | ||
| 2016-06-30 | 34.42M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-06 | 34.42M shares derived: average of 2 quarters · filed 2016-09-06 | 34.42M shares derived: average of 3 quarters · filed 2016-09-06 | 34.40M shares 10-K · filed 2016-09-06 | ||
| 2016-03-31 | 34.42M shares 10-Q · filed 2016-05-05 | 34.42M shares derived: average of 2 quarters · filed 2016-05-05 | 34.39M shares 10-Q · filed 2016-05-05 | 34.36M shares derived: average of 4 quarters · filed 2016-11-09 | ||
| 2015-12-31 | 34.42M shares 10-Q · filed 2016-02-05 | 34.38M shares 10-Q · filed 2016-02-05 | 34.34M shares derived: average of 3 quarters · filed 2016-11-09 | 34.12M shares derived: average of 4 quarters · filed 2016-11-09 | ||
| 2015-09-30 | 34.33M shares 10-Q · filed 2016-11-09 | 34.30M shares derived: average of 2 quarters · filed 2016-11-09 | 34.02M shares derived: average of 3 quarters · filed 2016-11-09 | 31.41M shares derived: average of 4 quarters · filed 2016-11-09 | ||
| 2015-06-30 | 34.27M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-06 | 33.87M shares derived: average of 2 quarters · filed 2016-09-06 | 30.44M shares derived: average of 3 quarters · filed 2016-09-06 | 28.20M shares 10-K · filed 2016-09-06 | ||
| 2015-03-31 | 33.47M shares 10-Q · filed 2016-05-05 | 28.53M shares derived: average of 2 quarters · filed 2016-05-05 | 26.18M shares 10-Q · filed 2016-05-05 | 25.08M shares derived: average of 4 quarters · filed 2016-09-06 | ||
| 2014-12-31 | 23.58M shares 10-Q · filed 2016-02-05 | 22.62M shares 10-Q · filed 2016-02-05 | 22.28M shares derived: average of 3 quarters · filed 2016-09-06 | 22.09M shares derived: average of 4 quarters · filed 2016-09-06 | ||
| 2014-09-30 | 21.65M shares 10-Q · filed 2015-11-06 | 21.63M shares derived: average of 2 quarters · filed 2016-09-06 | 21.59M shares derived: average of 3 quarters · filed 2016-09-06 | 21.21M shares derived: average of 4 quarters · filed 2016-09-06 | ||
| 2014-06-30 | 21.60M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-06 | 21.55M shares derived: average of 2 quarters · filed 2016-09-06 | 21.06M shares derived: average of 3 quarters · filed 2016-09-06 | 20.06M shares 10-K · filed 2016-09-06 | ||
| 2014-03-31 | 21.50M shares 10-Q · filed 2015-05-07 | 20.78M shares derived: average of 2 quarters · filed 2015-05-07 | 19.55M shares 10-Q · filed 2015-05-07 | 18.88M shares derived: average of 4 quarters · filed 2015-09-02 | ||
| 2013-12-31 | 20.07M shares 10-Q · filed 2015-02-06 | 18.59M shares 10-Q · filed 2015-02-06 | 18.00M shares derived: average of 3 quarters · filed 2015-09-02 | 17.26M shares derived: average of 4 quarters · filed 2015-09-02 | ||
| 2013-09-30 | 17.12M shares 10-Q · filed 2014-11-06 | 16.97M shares derived: average of 2 quarters · filed 2015-09-02 | 16.32M shares derived: average of 3 quarters · filed 2015-09-02 | 13.60M shares derived: average of 4 quarters · filed 2015-09-02 | ||
| 2013-06-30 | 16.82M shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-02 | 15.92M shares derived: average of 2 quarters · filed 2015-09-02 | 12.43M shares derived: average of 3 quarters · filed 2015-09-02 | 10.16M shares 10-K · filed 2015-09-02 | ||
| 2013-03-31 | 15.02M shares 10-Q · filed 2014-05-08 | 10.24M shares derived: average of 2 quarters · filed 2014-05-08 | 7.94M shares 10-Q · filed 2014-05-08 | 6.74M shares derived: average of 4 quarters · filed 2014-09-09 | ||
| 2012-12-31 | 5.46M shares 10-Q · filed 2014-02-11 | 4.48M shares 10-Q · filed 2014-02-11 | 3.98M shares derived: average of 3 quarters · filed 2014-09-09 | 3.59M shares derived: average of 4 quarters · filed 2014-09-09 | ||
| 2012-09-30 | 3.50M shares 10-Q · filed 2013-11-08 | 21.00M shares 10-Q · filed 2012-11-13 | 3.24M shares derived: average of 2 quarters · filed 2014-09-09 | 2.97M shares derived: average of 3 quarters · filed 2014-09-09 | 2.72M shares derived: average of 4 quarters · filed 2014-09-09 | |
| 2012-06-30 | 2.97M shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-09 | 2.71M shares derived: average of 2 quarters · filed 2014-09-09 | 2.47M shares derived: average of 3 quarters · filed 2014-09-09 | 2.25M shares 10-K · filed 2014-09-09 | 13.49M shares 10-K · filed 2012-09-18 | |
| 2012-03-31 | 2.44M shares 10-Q · filed 2013-05-09 | 2.21M shares derived: average of 2 quarters · filed 2013-05-09 | 2.01M shares 10-Q · filed 2013-05-09 | |||
| 2011-12-31 | 1.98M shares 10-Q · filed 2013-02-12 | 1.79M shares 10-Q · filed 2013-02-12 | ||||
| 2011-09-30 | 9.59M shares 10-Q · filed 2012-11-13 | |||||
| 2011-06-30 | 7.64M shares 10-K · filed 2012-09-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |